Sort   by:  
 Page size 
UnknownCost-effectiveness analysis of benmelstobart, anlotinib, and chemotherapy in extensive-stage small-cell lung cancer.
Not available
S-EPMC11625741 | biostudies-literature
UnknownGenetic variants in the 6p21.3 region influence hepatitis B virus clearance and chronic hepatitis B risk in the Han Chinese population.
Not available
S-EPMC11771252 | biostudies-literature
UnknownThe Wnt/β-catenin pathway maintains homeostasis of amniocytes in Down syndrome.
Not available
S-EPMC12947344 | biostudies-literature
UnknownCost-effectiveness analysis of adebrelimab combined with chemotherapy for extensive-stage small cell lung cancer.
Not available
S-EPMC9643856 | biostudies-literature
UnknownCost-effectiveness analysis of transarterial chemoembolization combined with lenvatinib as the first-line treatment for advanced hepatocellular carcinoma.
Not available
S-EPMC10512705 | biostudies-literature
UnknownCost-effectiveness analysis of sintilimab plus chemotherapy for advanced or metastatic esophageal squamous cell carcinoma.
Not available
S-EPMC9773135 | biostudies-literature
UnknownImplementation of convolutional neural networks for microbial colony recognition.
Not available
S-EPMC12403611 | biostudies-literature
UnknownCost-effective analysis of sugemalimab plus chemotherapy as first-line treatment for advanced gastric or gastroesophageal junction adenocarcinoma with PD-L1 CPS ≥5.
Not available
S-EPMC12411535 | biostudies-literature
UnknownCost-effectiveness analysis of zolbetuximab plus mFOLFOX6 as the first-line treatment for CLDN18.2-positive, HER2-negative advanced gastric or Gastroesophageal Adenocarcinoma.
Not available
S-EPMC10500349 | biostudies-literature
UnknownDecreased tubulin-binding cofactor B was involved in the formation disorder of nascent astrocyte processes by regulating microtubule plus-end growth through binding with end-binding proteins 1 and 3 after chronic alcohol exposure.
Not available
S-EPMC9641617 | biostudies-literature
Sort   by:  
 Page size